Research Article

Prognosis Risk of Urosepsis in Critical Care Medicine: A Prospective Observational Study

Table 3

Subgroup analysis of urosepsis patients.

Transferred from the department of urinary surgery
()
Transferred from other departments
()
value

Time before being sent to ICU (hours)11.6 ± 7.37.2 ± 4.92.2390.032
Positive blood culture rate14 (82%)13 (68%)0.9290.335
Percentage with combination diseases5 (29%)11 (58%)2.9480.086
SOFA score5.7 ± 2.16.0 ± 1.8−0.4620.647
APACHE II score18.8 ± 6.222.4 ± 5.6−1.8310.076
Mechanical ventilation9 (53%)11 (58%)0.0890.765
CRRT4 (24%)6 (31%)0.2900.590
Vasoactive drugs use8 (47%)9 (47%)<0.0010.985
WBC count (×109/L)5.9 ± 5.16.4 ± 5.7−0.2760.784
PLT (×109/L)81.0 ± 35.685.7 ± 32.3−0.4150.680
MAP (mmHg)89.4 ± 20.593.2 ± 18.8−0.5800.566
Serum creatinine (μmol/L)123.6 ± 50.9126.4 ± 48.6−0.1690.867
Bilirubin (μmol/L)16.8 ± 4.214.5 ± 3.71.7470.090
28-day mortality1 (6%)1 (5%)0.0070.935
90-day mortality1 (6%)1 (5%)0.0070.935

APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment; ICU, intensive care unit; WBC, white blood cell; PLT, platelet; MAP, mean arterial pressure; CRRT, continuous renal replacement therapy.